SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-014207
Filing Date
2020-12-07
Accepted
2020-12-07 11:18:43
Documents
14
Period of Report
2020-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20201204x8k.htm   iXBRL 8-K 49489
2 EX-99.1 xncr-20201204xex99d1.htm EX-99.1 16374
3 GRAPHIC xncr-20201204xex99d1001.jpg GRAPHIC 5434
  Complete submission text file 0001558370-20-014207.txt   196933

Data Files

Seq Description Document Type Size
4 EX-101.SCH xncr-20201204.xsd EX-101.SCH 2975
5 EX-101.LAB xncr-20201204_lab.xml EX-101.LAB 15410
6 EX-101.PRE xncr-20201204_pre.xml EX-101.PRE 9959
7 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20201204x8k_htm.xml XML 4663
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 201371722
SIC: 2834 Pharmaceutical Preparations